[go: up one dir, main page]

FI946043L - Sokeripäällysteinen farmaseuttinen annosyksikkö - Google Patents

Sokeripäällysteinen farmaseuttinen annosyksikkö Download PDF

Info

Publication number
FI946043L
FI946043L FI946043A FI946043A FI946043L FI 946043 L FI946043 L FI 946043L FI 946043 A FI946043 A FI 946043A FI 946043 A FI946043 A FI 946043A FI 946043 L FI946043 L FI 946043L
Authority
FI
Finland
Prior art keywords
sugar
dosage unit
pharmaceutical dosage
coated pharmaceutical
coated
Prior art date
Application number
FI946043A
Other languages
English (en)
Swedish (sv)
Other versions
FI116035B (fi
FI946043A0 (fi
Inventor
Haan Pieter De
Marcus Johannes Maria Deurloo
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of FI946043A0 publication Critical patent/FI946043A0/fi
Publication of FI946043L publication Critical patent/FI946043L/fi
Application granted granted Critical
Publication of FI116035B publication Critical patent/FI116035B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
FI946043A 1993-12-23 1994-12-22 Menetelmä sokeripäällysteisen farmaseuttisen annosyksikön valmistamiseksi FI116035B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93203645 1993-12-23
EP93203645 1993-12-23

Publications (3)

Publication Number Publication Date
FI946043A0 FI946043A0 (fi) 1994-12-22
FI946043L true FI946043L (fi) 1995-06-24
FI116035B FI116035B (fi) 2005-09-15

Family

ID=8214236

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946043A FI116035B (fi) 1993-12-23 1994-12-22 Menetelmä sokeripäällysteisen farmaseuttisen annosyksikön valmistamiseksi

Country Status (16)

Country Link
US (1) US5662936A (fi)
EP (1) EP0659432B1 (fi)
JP (1) JPH07206681A (fi)
KR (1) KR100330560B1 (fi)
CN (1) CN1108929A (fi)
AT (1) ATE155039T1 (fi)
AU (1) AU685538B2 (fi)
CA (1) CA2138451C (fi)
DE (2) DE659432T1 (fi)
DK (1) DK0659432T3 (fi)
ES (1) ES2105501T3 (fi)
FI (1) FI116035B (fi)
GR (1) GR3024817T3 (fi)
NO (1) NO305273B1 (fi)
NZ (1) NZ270228A (fi)
ZA (1) ZA949929B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
EP1488794A3 (en) * 1994-11-22 2005-04-20 Balance Pharmaceuticals, Inc. Methods of contraception
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
ATE195871T1 (de) * 1997-09-23 2000-09-15 Akzo Nobel Nv Steroid enthaltende dosierungsformen mit einer steroiddichten umhüllung
AU777278B2 (en) 1999-06-05 2004-10-07 Innovata Biomed Limited Delivery system
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
HUP0203626A2 (en) * 1999-10-11 2003-02-28 Ml Lab Plc Medicament delivery device with moisture resistant coating
US6254888B1 (en) * 2000-01-28 2001-07-03 Boehringer Ingelheim Pharmaceuticals, Inc. Method for coating pharmaceutical dosage forms
AU4278301A (en) * 2000-03-27 2001-10-08 Kyowa Hakko Kogyo Co. Ltd. Easy-to-take granule
DE60116758T2 (de) * 2000-05-18 2006-11-02 Therics, Inc. Einkapselung eines toxischen kerns in einen nicht-toxischen bereich in einer oralen darreichungsform
JP2002068965A (ja) * 2000-08-31 2002-03-08 Teikoku Hormone Mfg Co Ltd 単層糖衣錠及びその製造方法
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US8092831B2 (en) * 2002-11-08 2012-01-10 Andrx Pharmaceuticals, Llc Antihistamine and decongestant system
JP2007533387A (ja) 2004-04-21 2007-11-22 イノベータ バイオメド リミテッド 吸入器
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
US20080050605A1 (en) * 2004-10-15 2008-02-28 Rapp Knut M Pan Coating Process
JP4808453B2 (ja) * 2005-08-26 2011-11-02 株式会社荏原製作所 研磨方法及び研磨装置
WO2007035961A2 (en) * 2005-09-23 2007-03-29 Threshold Pharmaceuticals, Inc. Anti-cancer therapies
BR112013016376A2 (pt) * 2010-12-29 2018-06-19 Nestec S.A. produto de confeitos compreendendo pó de óleo aglomerado
US20150157040A1 (en) * 2012-07-03 2015-06-11 Nestec S.A. Confectionery product comprising agglomerated oil powder
US20150290136A1 (en) * 2012-11-22 2015-10-15 Evonik Roehm Gmbh Process for preparing a granulated product from a powder composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2736682A (en) * 1954-10-11 1956-02-28 Victor M Hermelin Method of making a prolonged action medicinal tablet
US3576663A (en) * 1967-05-29 1971-04-27 Colorcon Coated tablet
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations

Also Published As

Publication number Publication date
KR950016715A (ko) 1995-07-20
AU685538B2 (en) 1998-01-22
EP0659432B1 (en) 1997-07-09
US5662936A (en) 1997-09-02
JPH07206681A (ja) 1995-08-08
CA2138451C (en) 2007-04-24
FI116035B (fi) 2005-09-15
KR100330560B1 (ko) 2002-09-05
CA2138451A1 (en) 1995-06-24
DE659432T1 (de) 1997-01-30
NO944991L (no) 1995-06-26
FI946043A0 (fi) 1994-12-22
NO944991D0 (no) 1994-12-22
ES2105501T3 (es) 1997-10-16
AU8168494A (en) 1995-06-29
CN1108929A (zh) 1995-09-27
DK0659432T3 (da) 1998-02-16
ZA949929B (en) 1995-08-23
EP0659432A1 (en) 1995-06-28
DE69404116T2 (de) 1997-11-13
NZ270228A (en) 1995-09-26
NO305273B1 (no) 1999-05-03
GR3024817T3 (en) 1998-01-30
DE69404116D1 (de) 1997-08-14
ATE155039T1 (de) 1997-07-15

Similar Documents

Publication Publication Date Title
FI946043L (fi) Sokeripäällysteinen farmaseuttinen annosyksikkö
FI955907A7 (fi) Laite farmaseuttisten aineiden antamiseksi
FI973243L (fi) Uusi farmaseuttinen yhdistelmä
FI944832L (fi) Farmaseuttinen koostumus
NO930677D0 (no) Farmasoeytiske forbindelser
FI923581A7 (fi) Farmaseuttinen yhdistelmämuodostelu
FI943018A7 (fi) Terapeuttisia aineita
NO931831D0 (no) Farmasoeytiske blandinger
NO981008D0 (no) Farmasöytisk formulering
FI961630A7 (fi) Terapeuttisia aineita
FI924744A7 (fi) Terapeuttisia aineita
ITMI932540A0 (it) Composizione farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
NO934145L (no) Farmasöytiske forbindelser
NO931008D0 (no) Farmasoeytiske forbindelser
FI943705L (fi) Farmaseuttiset koostumukset
NO961589D0 (no) Farmasöytiske blandinger
FI973230A7 (fi) Uusi farmaseuttinen formulaatio
FI940726A7 (fi) Farmaseuttiset koostumukset
LV10579A (lv) Farmaceitiska kompozicija
FI923662A7 (fi) Terapeuttisia aineita
FI921785A7 (fi) Farmaceutisk foerening
FI921786A7 (fi) Farmaceutisk foerening
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
FI942803A0 (fi) Ipsapironi-lääkevalmiste

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116035

Country of ref document: FI

PC Transfer of assignment of patent

Owner name: N.V. ORGANON

Free format text: N.V. ORGANON